Drug recalls

Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only,…

VITRUVIAS THERAPEUTICS INC · Superpotent Drug

Class IOngoingD-0866-2026
Status
Ongoing
City
Auburn
State
AL
Country
United States
Classification
Class I
Product type
Drugs
Event ID
99709
Recalling firm
VITRUVIAS THERAPEUTICS INC
Address 1
778 N Dean Rd Ste 600
Address 2
N/A
Postal code
36830-4318
Voluntary mandated
Voluntary: Firm initiated
Initial firm notification
Letter
Distribution pattern
US Nationwide.
Recall number
D-0866-2026
Product quantity
1955 bottles
Reason for recall
Superpotent Drug
Recall initiation date
20260821
Center classification date
20260922
Report date
20260923
Code info
Lot # 504950, Exp Date: 09/30/2026.
Product description

Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.

Harmonized identifiers (openFDA)
Brand name
THYROID
Generic name
THYROID
Manufacturer name
Vitruvias Therapeutics
Product NDC
69680-165, 69680-166, 69680-167, 69680-168, 69680-169
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
THYROID
RxCUI
208545, 313387, 313391, 313393, 314267
SPL ID
0a6961da-1a42-4233-b6be-7e2d3a930353
SPL set ID
b1085f7c-70b3-4850-89c0-5d2b3c6c46cf
Package NDC
69680-165-00, 69680-166-00, 69680-167-00, 69680-168-00, 69680-169-00
Is original packager
true
UNII
6RV024OAUQ
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.